Calls
1
u/theInquisitivePanda
Reddit r/wallstreetbets
Win Rate
0.0%
return
-38.1%
Loading charts...
Ticker
Side
Mentions
Opened
Entry
P&L
Thesis
Theme
Source
Short
Mar 23
$36.53
-38.1%
NVO's key patent for semaglutide has expired in India, with $14 generics hitting the market, and China's patent is expiring soon. The introduction of ultra-cheap generics in the world's two most populous countries will severely undercut NVO's pricing power and capture international market share. The international patent cliff for NVO's blockbuster drugs creates a bearish headwind for the stock's global growth narrative. NVO's primary revenue and profit centers are the US and Europe, where patents remain intact and demand still vastly outstrips supply.
NVO's key patent for semaglutide has expired in India, with $14 generics hitting the market, and China's patent is expiring soon. The introduction of ultra-cheap generics in the world's two most populous countries will severely undercut NVO's pricing power and capture international market share. The international patent cliff for NVO's blockbuster drugs creates a bearish headwind for the stock's global growth narrative. NVO's primary revenue and profit centers are the US and Europe, where patents remain intact and demand still vastly outstrips supply.
Healthcare
Showing 1 of 1 picks · sorted by mentions
Choose a mentions count to open ticker posts.
u/theInquisitivePanda has 1 trade ideas tracked on Buzzberg across 1 tickers since March 2026. Most covered: NVO.
